for Nanotech Formulation of Delta9
Selected Abstract
Aphios Awarded SBIR Grant from National Institute on Drug Abuse (NIDA) for Nanotech Formulation of Delta9-THC for Marijuana Addiction and Other Unmet Medical Needs.
WOBURN, Mass. -- Aphios Corporation today announced receipt of a Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Drug Abuse (NIDA) to develop an improved oral formulation of 9-THC for marijuana addiction and unmet medical needs. According to Dr. Trevor P. ... October 28, 2008; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Aphios Awarded SBIR Grant from National Institute on Drug Abuse (NIDA) for Nanotech Formulation of Delta9-THC for Marijuana Addiction and Other Unmet Medical Needs.
|
